Free Trial

TD Cowen Forecasts Strong Price Appreciation for Xylem (NYSE:XYL) Stock

Xylem logo with Business Services background

Key Points

  • TD Cowen has raised its price target for Xylem (NYSE: XYL) from $125.00 to $130.00, maintaining a "hold" rating despite the target suggesting an 8.93% downside from the previous close.
  • Other analysts have varying opinions, with Royal Bank of Canada setting a higher price target of $147.00 and Citigroup raising their target to $152.00, indicating a generally positive outlook among analysts.
  • Xylem's recent earnings report showed an earnings per share (EPS) of $1.26, exceeding estimates, and the company projects FY 2025 EPS guidance between 4.700 and 4.850.
  • Need better tools to track Xylem? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Xylem (NYSE:XYL - Get Free Report) had its price target boosted by stock analysts at TD Cowen from $125.00 to $130.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a "hold" rating on the industrial products company's stock. TD Cowen's target price would suggest a potential downside of 8.93% from the company's previous close.

A number of other equities analysts have also issued reports on the stock. Royal Bank Of Canada raised their target price on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Robert W. Baird lowered their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 30th. Citigroup reiterated a "buy" rating and issued a $152.00 price objective (up from $137.00) on shares of Xylem in a research report on Monday, July 14th. JPMorgan Chase & Co. assumed coverage on shares of Xylem in a research report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective on the stock. Finally, Raymond James Financial upgraded shares of Xylem to a "hold" rating in a research report on Thursday, May 15th. Six equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $152.29.

Get Our Latest Analysis on Xylem

Xylem Stock Performance

Shares of XYL opened at $142.7550 on Tuesday. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The firm has a market cap of $34.75 billion, a PE ratio of 37.08, a price-to-earnings-growth ratio of 2.49 and a beta of 1.11. The company's 50 day simple moving average is $134.57 and its 200-day simple moving average is $126.47. Xylem has a 12-month low of $100.47 and a 12-month high of $145.33.

Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. The business had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period last year, the firm posted $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities analysts predict that Xylem will post 4.65 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of XYL. Price T Rowe Associates Inc. MD raised its position in Xylem by 689.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock worth $443,074,000 after acquiring an additional 3,239,203 shares in the last quarter. Norges Bank acquired a new stake in Xylem in the second quarter valued at $338,232,000. ABN AMRO Bank N.V. acquired a new stake in Xylem in the second quarter valued at $208,226,000. Northern Trust Corp grew its holdings in Xylem by 42.0% in the fourth quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock valued at $379,204,000 after purchasing an additional 966,399 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in Xylem in the first quarter valued at $99,726,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Company Profile

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Analyst Recommendations for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines